Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221713 | 1.00 | CES2 (0.50) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL1122749 | 1.00 | CES2 (0.50) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL642121 | 1.00 | CES2 (0.50) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL791540 | 1.00 | CES2 (0.50) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL399595 | 0.97 | CES2 (0.46) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL29207086 | 0.95 | CES2 (0.46) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL4962068 | 0.92 | — | — | |
| Acrylic Acid SCHEMBL1715031 | 0.89 | LMNA (0.42) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL20838334 | 0.86 | SMN1; SMN2 (0.39) | CES2CES1TSHRSMN1; SMN2POLB | |
| SCHEMBL26124 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023052127-A1 | PVC MIXTURE | LEONI KABEL GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| CN-113166642-A | Polymeric chromophores, compositions comprising the same, and methods of making and using the same | 北卡罗莱纳州立大学 | 2021-07-23 | — | — | CN | disclosed |
| EP-3201261-B1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2018-12-12 | — | — | EP | disclosed |
| EP-3201261-A1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2017-08-09 | — | — | EP | disclosed |
| EP-3066161-B1 | COATINGS FOR USE AS ADHESIVE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2017-07-05 | — | — | EP | disclosed |
| EP-3066161-A1 | NOVEL BINDING AGENT SYSTEMS | Construction Research & Technology GmbH (DE) | 2016-09-14 | — | — | EP | disclosed |
| WO-2016050398-A1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2016-04-07 | — | — | WO | disclosed |
| WO-2015067478-A1 | NOVEL BINDING AGENT SYSTEMS | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2015-05-14 | — | — | WO | disclosed |
| EP-1695146-B1 | COATING MATERIALS CONTAINING alpha-(1 -HYDROXYALKYL)ACRYLATES | BASF SE (DE) | 2008-04-16 | — | — | EP | disclosed |
| US-20070203136-A1 | TRIAZOLOPYRIDAZINES AS KINASE MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-08-30 | — | — | US | disclosed |
| EP-1695146-A1 | COATING MATERIALS CONTAINING alpha-(1 -HYDROXYALKYL)ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005057286-A1 | COATING MATERIALS CONTAINING α-(1'-HYDROXYALKYL)ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-23 | — | — | WO | disclosed |
| US-5798119-A | HYDROPHILIC FORMULATION AND BENEFICIAL AGENT SURROUNDED BY WALL COMPRISING SEMIPERMEABLE HYDROPHOBIC MICROPOROUS MEMBRANE; BLOOD OXYGENATORS, MEMBRANE DISTILLATION PROCESSES | S. C. JOHNSON & SON, INC. (US) | 1998-08-25 | — | — | US | disclosed |
| WO-1996041621-A2 | OSMOTIC-DELIVERY DEVICES HAVING VAPOR-PERMEABLE COATINGS | S.C. JOHNSON & SON, INC. (US) | 1996-12-27 | — | — | WO | disclosed |
| EP-0711146-A1 | OSMOTIC DEVICES HAVING VAPOR-PERMEABLE COATINGS | PFIZER INC. (US) | 1996-05-15 | — | — | EP | disclosed |
| EP-0552603-B1 | Soluble polymers | BASF AG (DE) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995003033-A1 | OSMOTIC DEVICES HAVING VAPOR-PERMEABLE COATINGS | PFIZER INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| EP-0552603-A1 | Soluble polymers | BASF Aktiengesellschaft (DE) | 1993-07-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203136-A1 | TRIAZOLOPYRIDAZINES AS KINASE MODULATORS | RET, MET, ABL1 | CES2 1776/4885CES1 1805/4885HDAC8 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.